Immediate Impact

26 standout
Sub-graph 1 of 9

Citing Papers

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Renal Cell Carcinoma
2024 Standout
3 intermediate papers

Works of Mary Achim being referenced

Improving risk-stratification of localized prostate cancer in a prospective active surveillance cohort.
2018
Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System
2015

Author Peers

Author Last Decade Papers Cites
Mary Achim 260 96 75 23 310
C. Surcel 265 78 64 19 289
Walsh Pc 288 69 78 23 358
Alex Gorbonos 284 105 56 32 340
Raghu Rajan 101 57 97 20 360
Arnas Rakauskas 256 101 44 18 286
Igor Nunes‐Silva 243 83 47 27 279
Shivaram Cumarasamy 244 82 56 23 279
Jean‐Paul A. van Basten 214 89 76 25 273
E. Martinez 239 45 81 19 323
Peter P. Lai 235 67 101 14 344

All Works

Loading papers...

Rankless by CCL
2026